General information about company

Scrip code*540204
NSE Symbol*NOTLISTED
MSEI Symbol*NOTLISTED
ISIN*INE666Q01016
Name of companyEIKO LIFESCIENCES LIMITED
Type of companyMain Board
Class of securityEquity
Date of start of financial year01-04-2025
Date of end of financial year31-03-2026
Date of board meeting when results were approved26-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange21-05-2026
Description of presentation currencyINR
Level of roundingLakhs
Reporting TypeQuarterly
Reporting QuarterFourth quarter
Nature of report standalone or consolidatedConsolidated
Whether results are audited or unaudited for the quarter endedAudited
Whether results are audited or unaudited for the Year to date for current period ended/year endedAudited
Segment ReportingMulti segment
Description of single segment
Start date and time of board meeting26-05-2026 11:00
End date and time of board meeting26-05-2026 13:00
Whether cash flow statement is applicable on companyYes
Type of cash flow statementCash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualificationDeclaration of unmodified opinion



Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-01-202601-04-2025
Date of end of reporting period31-03-202631-03-2026
Whether results are audited or unauditedAuditedAudited
Nature of report standalone or consolidatedConsolidatedConsolidated
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1Income
Revenue from operations1833.985270.66
Other income12.9597.28
Total income1846.935367.94
2Expenses
(a)Cost of materials consumed1665.64128.22
(b)Purchases of stock-in-trade00
(c)Changes in inventories of finished goods, work-in-progress and stock-in-trade-159.351.31
(d)Employee benefit expense 20.7766.63
(e)Finance costs11.5132.97
(f)Depreciation, depletion and amortisation expense25.24101.6
(g)Other Expenses
1Other Expenses78.4330.74
Total other expenses78.4330.74
Total expenses1642.174661.47
3Total profit before exceptional items and tax204.76706.47
4Exceptional items 00
5Total profit before tax204.76706.47
6Tax expense
7Current tax44.76150.46
8Deferred tax7.428.84
9Total tax expenses52.16179.3
10Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement00
11Net Profit Loss for the period from continuing operations152.6527.17
12Profit (loss) from discontinued operations before tax00
13Tax expense of discontinued operations00
14Net profit (loss) from discontinued operation after tax00
15Share of profit (loss) of associates and joint ventures accounted for using equity method-2.885.3
16Total profit (loss) for period149.72532.47
17Other comprehensive income net of taxes00
18Total Comprehensive Income for the period149.72532.47
19Total profit or loss, attributable to
Profit or loss, attributable to owners of parent130.01449.63
Total profit or loss, attributable to non-controlling interests19.782.84
20Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent130.01449.63
Total comprehensive income for the period attributable to owners of parent non-controlling interests19.782.84
21Details of equity share capital
Paid-up equity share capital1434.591434.59
Face value of equity share capital1010
22Reserves excluding revaluation reserve5037.66
23Earnings per share
iEarnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations0.933.26
Diluted earnings (loss) per share from continuing operations0.863.19
iiEarnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations00
Diluted earnings (loss) per share from discontinued operations00
iiiEarnings per equity share (for continuing and discontinued operations)
Basic earnings (loss) per share from continuing and discontinued operations0.933.26
Diluted earnings (loss) per share from continuing and discontinued operations0.863.19
24Debt equity ratioTextual Information( 1)
25Debt service coverage ratioTextual Information( 2)
26Interest service coverage ratioTextual Information( 3)
27Disclosure of notes on financial resultsTextual Information(4)

Statement of Asset and Liabilities

ParticularsYear ended (dd-mm-yyyy)
Date of start of reporting period01-04-2025
Date of end of reporting period31-03-2026
Whether results are audited or unauditedAudited
Nature of report standalone or consolidatedConsolidated
Assets
1 Non-current assets
Property, plant and equipment2210.31
Capital work-in-progress0
Investment property0
Goodwill0
Other intangible assets0
Intangible assets under development0
Biological assets other than bearer plants0
Investments accounted for using equity method0
Non-current financial assets
Non-current investments1529.37
Trade receivables, non-current0
Loans, non-current456.56
Other non-current financial assets
1
2
3
4
5
Details of other non-current financial assets
Total of other non-current financial assets
Total non-current financial assets1985.93
Deferred tax assets (net)
Other non-current assets
1
2
3
4
5
Details of other non-current assets
Total of other non-current assets
Total non-current assets4196.24
2Current assets
Inventories397.24
Current financial asset
Current investments0
Trade receivables, current2021.77
Cash and cash equivalents1361.42
Bank balance other than cash and cash equivalents0
Loans, current0
Other current financial assets
1
2
3
4
5
Details of other current financial assets
Total of Other current financial assets
Total current financial assets3383.19
Current tax assets (net)
Other current assets
1Other current assets960.3
2
3
4
5
Details of other current assets
Total of other current assets960.3
Total current assets4740.73
3Non-current assets classified as held for sale0
4Regulatory deferral account debit balances and related deferred tax Assets0
Total assets8936.97
Equity and liabilities
1Equity
Equity attributable to owners of parent
Equity share capital1434.59
Other equity5443.28
Total equity attributable to owners of parent6877.87
Non controlling interest104.61
Total equity6982.48
2Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current305.59
Trade Payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises0
Total Trade payable0
Other non-current financial liabilities
1
2
3
4
5
Details of other non-current financial liabilities
Total of other non-current financial liabilities
Total non-current financial liabilities305.59
Provisions, non-current0
Deferred tax liabilities (net)110.96
Deferred government grants, Non-current
Other non-current liabilities
1
2
3
4
5
Details of other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities416.55
Current liabilities
Current financial liabilities
Borrowings, current167.45
Trade Payables, current
(A) Total outstanding dues of micro enterprises and small enterprises0
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises1255.95
Total Trade payable1255.95
Other current financial liabilities
1
2
3
4
5
Details of other current financial liabilities
Total of other current financial liabilities
Total current financial liabilities1423.4
Other current liabilities
1Other current liabilities63.41
2
3
4
5
Details of other current liabilities
Total of other current liabilities63.41
Provisions, current18.15
Current tax liabilities (Net)32.98
Deferred government grants, Current0
Total current liabilities1537.94
3Liabilities directly associated with assets in disposal group classified as held for sale0
4Regulatory deferral account credit balances and related deferred tax liability0
Total liabilities1954.49
Total equity and liabilities8936.97
Disclosure of notes on assets and liabilitiesTextual Information(1)

Text Block

Textual Information(1)Money received against Share Warrants is shown under Other Equity.



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars3 months/ 6 month ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-01-202601-04-2025
Date of end of reporting period31-03-202631-03-2026
Whether results are audited or unauditedAuditedAudited
Nature of report standalone or consolidatedConsolidatedConsolidated
1Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1Speciality Chemicals & Pharma Intermediates1688.374602.75
2Logistics Services145.61667.9
Total Segment Revenue1833.985270.65
Less: Inter segment revenue
Revenue from operations 1833.985270.65
2Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1Speciality Chemicals & Pharma Intermediates125.34323.4
2Logistics Services28.93121.25
Total Profit before tax154.27444.65
i. Finance cost11.5232.97
ii. Other Unallocable Expenditure net off Unallocable income-59.12-300.09
Profit before tax201.87711.77
3(Segment Asset - Segment Liabilities)
Segment Asset
1Speciality Chemicals & Pharma Intermediates4337.364337.36
2Logistics Services1716.321716.32
Total Segment Asset6053.686053.68
Un-allocable Assets2883.292883.29
Net Segment Asset8936.978936.97
4Segment Liabilities
Segment Liabilities
1Speciality Chemicals & Pharma Intermediates1546.431546.43
2Logistics Services408.06408.06
Total Segment Liabilities1954.491954.49
Un-allocable Liabilities00
Net Segment Liabilities1954.491954.49
Disclosure of notes on segments

Other Comprehensive Income

Date of start of reporting period01-01-202601-04-2025
Date of end of reporting period31-03-202631-03-2026
Whether results are audited or unauditedAuditedAudited
Nature of report standalone or consolidatedConsolidatedConsolidated
Other comprehensive income [Abstract]
1Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2Income tax relating to items that will not be reclassified to profit or loss 0.000.00
3Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4Income tax relating to items that will be reclassified to profit or loss 0.000.00
5Total Other comprehensive income0.000.00


Cash flow statement, indirect

ParticularsYear ended (dd-mm-yyyy)
Date of start of reporting period01-04-2025
Date of end of reporting period31-03-2026
Whether results are audited or unauditedAudited
Nature of report standalone or consolidatedConsolidated
Part IBlue color marked fields are non-mandatory.
1Statement of cash flows
Cash flows from used in operating activities
Profit before tax706.47
2Adjustments for reconcile profit (loss)
Adjustments for finance costs32.98
Adjustments for decrease (increase) in inventories180.24
Adjustments for decrease (increase) in trade receivables, current-943.2
Adjustments for decrease (increase) in trade receivables, non-current0
Adjustments for decrease (increase) in other current assets-506.73
Adjustments for decrease (increase) in other non-current assets0
Adjustments for other financial assets, non-current0
Adjustments for other financial assets, current0
Adjustments for other bank balances0
Adjustments for increase (decrease) in trade payables, current924.47
Adjustments for increase (decrease) in trade payables, non-current0
Adjustments for increase (decrease) in other current liabilities-115.77
Adjustments for increase (decrease) in other non-current liabilities91.93
Adjustments for depreciation and amortisation expense101.6
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss0
Adjustments for provisions, current1.39
Adjustments for provisions, non-current0
Adjustments for other financial liabilities, current0
Adjustments for other financial liabilities, non-current0
Adjustments for unrealised foreign exchange losses gains0
Adjustments for dividend income0
Adjustments for interest income0
Adjustments for share-based payments0
Adjustments for fair value losses (gains)0
Adjustments for undistributed profits of associates0
Other adjustments for which cash effects are investing or financing cash flow0
Other adjustments to reconcile profit (loss)0
Other adjustments for non-cash items0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships0
Total adjustments for reconcile profit (loss)-233.09
Net cash flows from (used in) operations473.38
Dividends received0
Interest paid103.92
Interest received0
Income taxes paid (refund)141.1
Other inflows (outflows) of cash0
Net cash flows from (used in) operating activities228.36
3Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses0
Cash flows used in obtaining control of subsidiaries or other businesses0
Other cash receipts from sales of equity or debt instruments of other entities0
Other cash payments to acquire equity or debt instruments of other entities0
Other cash receipts from sales of interests in joint ventures0
Other cash payments to acquire interests in joint ventures0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships0
Proceeds from sales of property, plant and equipment0
Purchase of property, plant and equipment0
Proceeds from sales of investment property-808.67
Purchase of investment property0
Proceeds from sales of intangible assets0
Purchase of intangible assets0
Proceeds from sales of intangible assets under development0
Purchase of intangible assets under development0
Proceeds from sales of goodwill0
Purchase of goodwill0
Proceeds from biological assets other than bearer plants0
Purchase of biological assets other than bearer plants0
Proceeds from government grants0
Proceeds from sales of other long-term assets0
Purchase of other long-term assets0
Cash advances and loans made to other parties0
Cash receipts from repayment of advances and loans made to other parties-161.42
Cash payments for future contracts, forward contracts, option contracts and swap contracts0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts0
Dividends received0
Interest received103.93
Income taxes paid (refund)0
Other inflows (outflows) of cash0
Net cash flows from (used in) investing activities-866.16
4Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries0
Payments from changes in ownership interests in subsidiaries0
Proceeds from issuing shares749.38
Proceeds from issuing other equity instruments0
Payments to acquire or redeem entity's shares0
Payments of other equity instruments0
Proceeds from exercise of stock options0
Proceeds from issuing debentures notes bonds etc0
Proceeds from borrowings0
Repayments of borrowings-104.76
Payments of lease liabilities0
Dividends paid0
Interest paid32.98
Income taxes paid (refund)0
Other inflows (outflows) of cash0
Net cash flows from (used in) financing activities821.16
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes183.36
5Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents0
Net increase (decrease) in cash and cash equivalents183.36
Cash and cash equivalents cash flow statement at beginning of period1178.06
Cash and cash equivalents cash flow statement at end of period1361.42



Details of Impact of Audit Qualification

Whether results are audited or unauditedAudited
Declaration of unmodified opinion or statement on impact of audit qualificationDeclaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Consolidated resultsYes
Audit firm's nameWhether the firm holds a valid peer review certificate issued by Peer Review Board of ICAICertificate valid upto
1PSV Jain And AssociatesYes30-04-2029